Complications of anaesthesia in neuromuscular disorders.
The purpose of this review is to alert non-anaesthesiologists to the various complications from which patients with neuromuscular disorders and those susceptible to malignant hyperthermia can suffer during anaesthesia. The patient's outcome correlates with the quality of consultation between anaesthesiologists, surgeons, neurologists and cardiologists. Special precautions must be taken, since many anaesthetics and muscle relaxants can aggravate the clinical features or trigger life-threatening reactions. Complications frequently occur in these patients, although anaesthetic procedures have become safer by the reduced administration of suxamethonium and the use of total intravenous anaesthesia, new volatile anaesthetics and non-depolarising relaxants. This review provides a synopsis of pre-operative anaesthetic considerations and adverse drug effects on skeletal, cardiac and smooth muscle tissue. It describes the pathogenetic aspects of typical complications and introduces anaesthetic procedures for the various neuromuscular disorders, including regional anaesthesia for patients in whom a restriction of respiratory and/or cardiac function is predicted.
Klingler
Werner
W
Department of Anaesthesiology, Ulm University, Albert-Einstein-Allee 11, 89069 Ulm, Germany.
Lehmann-Horn
Frank
F
Jurkat-Rott
Karin
K
D000758:Anesthesia / Q000009:adverse effects*; D000818:Animals; D006801:Humans; D007431:Intraoperative Complications; D008305:Malignant Hyperthermia / Q000209:etiology; D020967:Myotonic Disorders / Q000209:etiology; D009468:Neuromuscular Diseases / Q000209:etiology* / Q000601:surgery; D012128:Respiratory Distress Syndrome / Q000209:etiology; D012206:Rhabdomyolysis / Q000209:etiology; D013035:Spasm / Q000209:etiology